Abstract
Introduction on the need of radiation safety regulations is highlighted in the beginning of the chapter. The linear non-threshold (LNT) model is given in brief while explaining the difference between stochastic and deterministic effects followed by the objective of radiation protection. The units of radiation dose (both SI and traditional) used in radiation safety are mentioned. After explaining the system of dose limitation, the annual dose limits for the occupational staff and public as recommended by ICRP (2007) are given in tabular form. The chapter deals with radiation safety in nuclear medicine in detail. Safety requirements and procedures in diagnostic (both conventional and PET) and therapeutic nuclear medicine have been described in detail. Radiation safety of staff, parents and public has been adequately covered. Emphasis has been given to good working habits (practice) for the staff while handling radioactivity in hot laboratory, injection site, imaging rooms, etc. The misadministration of radiopharmaceuticals to the patients and their avoidance has been appropriately described. Further the radiation emergencies in nuclear medicine and their management have also been included adequately. The text finally describes the management of radioactive waste in general and the waste generated in radioiodine therapy in particular.
Most of the text in this chapter has been reproduced from my book ‘Introduction to Basic Sciences of Nuclear Medicine’, Himalaya Publishing House, Mumbai, India, 2020 (under printing).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
International recommendations for X-ray and radium protection, Stockholm; 1929.
International recommendations on radiological protection: revised by the ICRP at the sixth international congress of radiology, London, July, 1950.
International commission on radiological protection Publication 103. Ann ICRP. 2007;37(2–4).
International commission on radiological protection. Statement on tissue reaction. Ann ICRP. 2011.
Courtney JC, Mendez P, Hidalgo-Salvatierra O, Bujenovic S. Photon shielding for a positron emission tomography suite. Health Phys. 2001;81(Suppl):S24–8.
Roberts FO, et al. Radiation dose to PET technologists and strategies to lower occupational exposure. J Nucl Med Technol. 2005;33:44–7.
National Radiological Protection Board (NRPB). Guidelines on patient dose to promote the optimisation of protection for diagnostic medical exposure (report of an advisory group on ionising radiation). 1999;10(2).
International Atomic Energy Agency. Nuclear medicine resource manual. Vienna: IAEA; 2006.
Hicks RJ, Binns D, Stabin MG. Pattern of uptake and excretion of 18F-FDG in the lactating breast. J Nucl Med. 2001;42(8):1238–42.
International Atomic Energy Agency (IAEA). Basic medical radiation safety package part a: principles of radiation safety; 2001.
International Atomic Energy Agency (IAEA) TECDOC-1183. Management of radioactive waste from the use of radionuclides in medicine; 2000.
Release of patients after radioiodine therapy. International Atomic Energy Agency with contributions from the ICRP, Safety report series 63. Vienna: IAEA; 2009.
Sisson JC, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011;21(4):335–46.
Barrington SF, Kettle AG, et al. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med. 1996;23:123–30.
Klerk John MH. 131I therapy: inpatient or outpatient? J Nucl Med. 2000;41:1876–8.
Beierwalts WH, Widman J. How harmful to others are Iodine-131 treated patients. J Nucl Med. 1992;33:2116–7.
Erkan I, Charles R, Wison B, et al. Iodine-131 contamination from thyroid cancer patients. J Nucl Med. 1992;33:2110–5.
European Thyroid Association Committee on Radioiodine. Euro J Nucl Med. 1996;23:13–15.
Mathieu I, Caussin J, Beckers C. Regulations and policies on radioiodine 131I therapy in Europe. Thyroid. 1997;7:221–4.
Pant GS, Sharma SK, Bal CS, Kumar R, Rath GK. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I. Radiat Prot Dosim. 2006;118(1):22–7.
Further Reading
International Atomic Energy Agency. Applying radiation safety standards in nuclear medicine. Safety Reports Series No. 40. Jointly sponsored by the International Atomic Energy Agency, International Labour Office, International Organisation for Medical Physics, Pan American Health Organisation, World Federation of Nuclear Medicine and Biology and World Health Organisation. Vienna: IAEA; 2005.
Nagaratnam A. Radiological protection: a summary handbook of ICRP publications and recommendations. New Delhi: DRDO, Min of Defence; 1995.
Pant GS. Radiation safety for unsealed sources. 2nd ed. Mumbai: Himalaya Publishing House; 2000.
Radiological protection of patients in diagnostic and interventional radiology, nuclear medicine and radiotherapy. In: Proceedings of Int conf, Spain. Vienna: IAEA; 2001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Appendices
Annexure 1: Radiation Weighting Factors
Radiation type | Radiation weighting factor, WR (ICRP 60) | Radiation weighting factor, WR (ICRP 103) |
---|---|---|
Photons | 1 | 1 |
Electronsa and muons | 1 | 1 |
Protons and charged pions | 5 | 2 |
Alpha particles, fission fragments, heavy ions | 20 | 20 |
Neutrons, energy <10Â keV | 5 | A continuous function of neutron energy |
 10–100 keV | 10 | |
 >100 keV to 2 MeV | 20 | |
 > 2–20 MeV | 10 | |
 >20 MeV | 5 |
Annexure 2: Tissue Weighting Factors (WT)
Organ/tissue | ICRP-60 (1991) | ICRP-103 (2007) |
---|---|---|
Bladder | 0.05 | 0.04 |
Bone | 0.01 | 0.01 |
Brain | – | 0.01 |
Breasts | 0.05 | 0.12 |
Colon | – | 0.12 |
Oesophagus | 0.05 | 0.04 |
Liver | 0.05 | 0.04 |
Lower large intestine | 0.12 | – |
Lungs | 0.12 | 0.12 |
Ovaries/testes | 0.20 | 0.08 |
Red marrow | 0.12 | 0.12 |
Salivary glands | – | 0.01 |
Skin | 0.01 | 0.01 |
Stomach | 0.12 | 0.12 |
Thyroid | 0.05 | 0.04 |
Remainder tissues | 0.05 | 0.12 |
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pant, G.S. (2021). Radiation Safety in Nuclear Medicine. In: Khalil, M.M. (eds) Basic Sciences of Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-65245-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-65245-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65244-9
Online ISBN: 978-3-030-65245-6
eBook Packages: MedicineMedicine (R0)